Stocks that tracked hedge funds and asset managers added to or newly bought in their latest 13F filings, while retail attention is still low — with the fund-by-fund share changes, estimated entry prices and an AI read on why they may be buying.
Next scan: tomorrow by 9:00 AM ET. A new scan is posted every Saturday by 9:00 AM ET.
5stocks qualified
5funds adding
5new positions
$2.77Bheld by those funds
AIThis scan
We compared the 2026-06-30 13F filings (filed Aug 14-15) against 2026-03-31 for all five configured managers: Berkshire, Bridgewater, Citadel, Renaissance Technologies, and Two Sigma. Roughly 2,000 CUSIPs cleared the raw acceleration screen (more buyers than sellers plus either +25% Q/Q aggregate shares or two new opens). After stripping mega-cap retail favorites, sector ETFs, sub-$1B and sub-$10M ADV names, and cross-referencing against a low-retail-attention filter, five names survived. The most surprising finding: Intercontinental Exchange (ICE) drew simultaneous cold opens from Bridgewater, Renaissance, and Two Sigma in the same quarter — a rare cross-style consensus for a $90B financial infrastructure name that has quietly rerated. Berkshire's fingerprint appears in a starter D.R. Horton position (3,564 shares), tiny in dollars but consistent with the wider Berkshire homebuilder cluster (Lennar A +30% Q/Q, LPX held) and the signal quality the "block-buy" carve-out was designed to preserve. The remaining three — Atmos Energy, McKesson, Viavi — are 4/0 buys-versus-sells with aggregate share counts up 131%, 174%, and 220% respectively, and neither Google Trends nor news volume shows retail waking up.
How this scan was run
Ranked CUSIP-level share deltas between the two most recent 13F-HR filings for each of the five configured funds. Excluded put-option holdings (hedges, not accumulation) and positions dominated (>80% of Q/Q increase) by a single non-Berkshire filer; Berkshire block buys were carved in per the desk convention. Retail-attention filter required at least two of: 30-day Google Trends ≤ 25 for ticker AND company name, 30-day mainstream news count ≤ 15, absence from r/wallstreetbets top-100 / StockTwits trending / major most-active lists, options call/put open-interest ratio below 2.0. Quant managers (Renaissance, Citadel, Two Sigma) were included in the buyer count but de-weighted in thesis-writing given intra-quarter turnover; Berkshire and Bridgewater carry more thesis weight. Average entry price estimate is aggregate Q2-end value divided by shares across supporting funds — this is a mark-to-market proxy, not true cost basis, and understates the buying window for funds that added late in the quarter. CUSIPs resolved via issuer-name match against Yahoo Finance and the SEC company_tickers.json cross-walk; Alphabet dual-class shares excluded from the shortlist as a mega-cap retail favorite. All five configured funds returned holdings for both quarters — no filings failed.
#1
ICE
Intercontinental Exchange Inc
FinancialsMkt cap $88.5BNext earnings Oct 29, 2026
Price
$155.47
Est. fund entry
$123.11+26.3%
Shares held
6.56M
Position value
$807.7M
Funds that added
Fund
Prior shares
Shares now
Change
Bridgewater Associates
—
38.9K
New position
Renaissance Technologies
—
1.27M
New position
Two Sigma Investments
—
2.03M
New position
Citadel Advisors
1.86M
3.22M
+73.3%
Retail attention 4 of 4 signals quiet
Google Trends18/100quiet
News, 30 days12 articlesquiet
Call/put OI1.40quiet
Retail hotlistsNot listedquiet
AIWhy these funds may be buying
Three of four non-Berkshire managers opened ICE cold in the same quarter — Bridgewater, Renaissance, and Two Sigma each moved from zero to a real weight while Citadel added 73% to its existing position. Aggregate holdings across the four funds jumped 253% Q/Q. ICE fits the Bridgewater 'financial rails' bucket (macro-neutral, fee-based cash flow) that Prince has been rotating into as macro dispersion widens, and the quant funds tend to open Bridgewater-style toll-road names when factor models flip toward quality-yield. The likely catalyst retail hasn't priced: the ICE Mortgage Technology segment finally clearing its integration overhang and fixed-income electronification volumes ramping into the 2026-Q4 print. Consensus still models flat organic growth in Mortgage; a beat there resets the multiple.
What would prove it wrong
Position has already rerated ~26% off the Q2 mark, so entry-timing edge is thinner than for the other four names. Regulatory pressure on data-fee pricing at exchange operators is the tail risk.
#2
MCK
McKesson Corporation
Health CareMkt cap $107.0BNext earnings Nov 4, 2026
Price
$874.65
Est. fund entry
$755.63+15.8%
Shares held
1.04M
Position value
$787.9M
Funds that added
Fund
Prior shares
Shares now
Change
Citadel Advisors
189.7K
601.8K
+217.2%
Renaissance Technologies
117.2K
361.1K
+208.0%
Two Sigma Investments
6.20K
9.45K
+52.4%
Bridgewater Associates
67.4K
70.4K
+4.4%
Retail attention 4 of 4 signals quiet
Google Trends8/100quiet
News, 30 days9 articlesquiet
Call/put OI1.10quiet
Retail hotlistsNot listedquiet
AIWhy these funds may be buying
All four non-Berkshire managers added MCK in Q2, with aggregate share count up 174% — but no one is talking about it. Drug distributors are structurally boring, which is exactly why quiet accumulation shows up here without triggering retail radar. Bridgewater's small trim-to-hold pattern says 'defensive weight,' Citadel and Renaissance tripling suggests both fundamental and factor models flipped positive on the same signal: specialty distribution margin mix. The under-priced catalyst is GLP-1 unit volume — McKesson is a primary distributor for the injectables — plus reimbursement clarity on 2027 Part D formularies. Consensus models a modest specialty ramp; the desk view is that Q3 already showed a step-function.
What would prove it wrong
Ongoing opioid-settlement cash outflows compress free cash conversion, and a hostile shift in generic drug pricing legislation could pressure the Rx Solutions segment.
#3
ATO
Atmos Energy Corporation
UtilitiesMkt cap $25.5BNext earnings Nov 4, 2026
Price
$160.30
Est. fund entry
$172.26-6.9%
Shares held
2.40M
Position value
$413.1M
Funds that added
Fund
Prior shares
Shares now
Change
Bridgewater Associates
—
3.59K
New position
Renaissance Technologies
166.8K
447.9K
+168.5%
Citadel Advisors
779.7K
1.76M
+126.2%
Two Sigma Investments
90.0K
183.1K
+103.5%
Retail attention 4 of 4 signals quiet
Google Trends6/100quiet
News, 30 days4 articlesquiet
Call/put OI0.90quiet
Retail hotlistsNot listedquiet
AIWhy these funds may be buying
A regulated natural gas utility is not where quant + macro funds usually collide — yet Renaissance more than doubled, Citadel doubled, Two Sigma doubled, and Bridgewater opened cold. Aggregate share count up 131% Q/Q on a name with a 6/100 Google Trends score. The likely thesis: Texas rate-case timing (ATO has ~70% of rate base in Texas) delivering step-up ROE in fiscal 2027, plus the AI data-center gas-demand story that has quietly pulled forward Permian midstream and downstream throughput assumptions. Bridgewater's cold open is the tell — Dalio's team rarely takes new utility exposure without a macro thesis behind it. The name trades below the Q2 mark, meaning the desk is entering at a discount to institutional average.
What would prove it wrong
Utilities remain rate-sensitive; a hawkish reset from the FOMC on stickier services inflation would compress the sector multiple. Regulatory delay on the Mid-Tex rate case is the name-specific overhang.
#4
VIAV
Viavi Solutions Inc
Information TechnologyMkt cap $8.0BNext earnings Oct 27, 2026
Price
$35.36
Est. fund entry
$47.76-26.0%
Shares held
7.70M
Position value
$367.5M
Funds that added
Fund
Prior shares
Shares now
Change
Two Sigma Investments
1.75M
5.59M
+219.3%
Citadel Advisors
535.8K
1.72M
+221.3%
Renaissance Technologies
110.0K
328.3K
+198.5%
Bridgewater Associates
7.60K
59.2K
+679.2%
Retail attention 4 of 4 signals quiet
Google Trends11/100quiet
News, 30 days6 articlesquiet
Call/put OI1.30quiet
Retail hotlistsNot listedquiet
AIWhy these funds may be buying
The smallest name on the list ($8B market cap) with the widest cross-fund conviction — every non-Berkshire manager roughly tripled or better, aggregate shares up 220%. Two Sigma alone now holds 5.6M shares. Viavi sells network test-and-measurement equipment plus optical security products; the cyclical trough in 5G lab spend appears to be turning, and the NITRO acquisition (announced Q1) closed cleanly into Q2. That the funds bought aggressively at ~$47 average and the stock has since drifted to $35 is precisely the retail-flow desk's setup: the institutions are underwater, retail hasn't noticed, and the fiscal-Q1 print on Oct 27 will either validate or invalidate the thesis with a hard number. Consensus expects flat sequential revenue.
What would prove it wrong
Small-cap tech test-equipment names have thin institutional following — if the Oct 27 print misses, the 220% Q/Q build could unwind into a liquidity-driven flush. NITRO integration execution is the key risk.
#5
DHI
D.R. Horton Inc
Consumer DiscretionaryMkt cap $41.0BNext earnings Oct 29, 2026
Price
$138.02
Est. fund entry
$162.86-15.3%
Shares held
2.44M
Position value
$397.9M
Funds that added
Fund
Prior shares
Shares now
Change
Berkshire Hathaway
—
3.56K
New position
Citadel Advisors
455.9K
888.6K
+94.9%
Two Sigma Investments
952.4K
1.47M
+54.0%
Bridgewater Associates
23.3K
42.8K
+83.8%
Retail attention 4 of 4 signals quiet
Google Trends22/100quiet
News, 30 days14 articlesquiet
Call/put OI1.60quiet
Retail hotlistsNot listedquiet
AIWhy these funds may be buying
The 3,564-share Berkshire starter looks trivial in isolation but is the actual signal — Buffett rarely opens a starter position without intent to scale. Read alongside Berkshire's +30% Q/Q Lennar A add and a static Louisiana-Pacific hold, this is a coherent homebuilder-cluster thesis. Three of four non-Berkshire funds also added: Citadel doubled, Two Sigma up 54%, Bridgewater up 84%. Renaissance trimmed — the only dissent, and consistent with their intra-quarter turnover profile. The catalyst retail hasn't priced: consensus mortgage-rate assumptions still model the 10-year Treasury at 4.2% into 2027; if the Fed's dot-plot dovish path holds, the affordability constraint that has capped orders resets fast. DHI is priced 15% below the institutional Q2 mark.
What would prove it wrong
If shelter inflation stays elevated and the Fed pauses on cuts, homebuilder orders miss into spring selling season. DHI's exposure to the entry-level buyer segment amplifies rate sensitivity.
Based on public SEC 13F filings. Funds file them up to 45 days after each quarter ends, so they show positions at quarter-end, not today. Average entry prices are estimates (filing value ÷ shares) — 13F filings don't report cost basis. The summaries, theses and risks are written by AI as a research aid — they are not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Institutional Flow tracks the quarterly 13F filings of a watchlist of hedge funds
and asset managers and flags the stocks several of them are accelerating into — new positions or sharply larger ones —
while search interest, news coverage and options positioning say the retail crowd hasn't noticed yet. It is free, and a
new scan is posted every Saturday by 9:00 AM ET. How to read Institutional Flow →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.